Purpose: The aim of this study was to determine proportions of upper third gastric cancer (UTG) among all gastric cancers and analyze clinicopathological features of the disease. Materials and Methods: The medical records of 12,300 patients who underwent gastric surgery between 1986 and 2006 at Seoul National University Hospital (SNUH) were retrospectively reviewed. Clinicopathological features of 1,260 patients with UTG and 9,929 patients with middle or lower third gastric cancer (MLG) were compared, and annual proportions of UTG were evaluated. Results: The proportion of patients with UTG rapidly increased from 2.6% in 1986 to 12.5% in 1992. However, linear regression analysis showed that the rate of increase was reduced (0.21%/year) after 1992 (12.5% to 14.2% from 1992 to 2006). Compared with the MLG group, the UTG group had a lower proportion of (22.3% vs. 39.7%, P<0.001) and a greater proportion of stage III/IV disease (39.4% vs. 31.7%, P<0.001). The UTG group also had larger tumors than the MLG group in stages I/II and III (3.5 cm/5.3 cm/6.5 cm vs. 3.2 cm/5.0 cm/5.8 cm, P=0.020/0.028 /<0.001), a higher proportion of undifferentiated cancer (63.1% vs. 53.7%, P<0.001), and less intestinal Lauren's type (38.8% vs. 47.4%, P<0.001). The 5-year survival rate of the UTG group was significantly lower than that of the MLG group in stages I/II and III (85.6%/63.1%/34.2% vs. 91.6%/ 69.2%/44.7%, P<0.001/0.028/0.006). Conclusions: The proportion of UTGs has increased over the last two decades at SNUH, but the rate of increase has been greatly reduced since 1992. The UTG group showed a poorer prognosis compared with the MLG group in stages I/II and III.
Introduction
Regional incidences of gastric cancer are variable, and the prevalence of the disease shows a declining tendency. However, gastric cancer remains the fourth most common malignancy worldwide, and there is a higher incidence of the disease in Far Eastern Asian countries, such as Korea and Japan. Nationwide Gastric Cancer Registry also reported similar findings.
(7) Such increases could be related to recent changes in lifestyles of the Korean population. Some studies in both Western and Eastern countries have reported a poorer prognosis with UTG. (8, 9) Others, however, found that the prognosis of patients with UTG was no poorer than that of patients with MLG in each equal TNM stage.
(10,11) It remains unclear whether the disease prognosis is due to different biologic characteristics or late detection. In this study, we evaluated chronological changes in the prevalence of UTG, the prognosis of UTG patients who underwent gastric resection at SNUH during the last 21 years, and potential prognostic indicators of UTG.
Materials and Methods
We retrospectively analyzed the medical records of 12 
Results
Among the 12,300 study group, 1,111 patients were excluded due to pre-operative chemotherapy (N=39), remnant gastric can- 
.4 cm).
When TNM stages were compared, the UTG group showed a significantly larger tumor size than the MLG group in all TNM stages except stage IV. There were some missing values in the cell differentiation and Lauren's classification categories due to limitations in medical records but the UTG group exhibited a significantly higher proportion of diffuse Lauren's type and a higher proportion of undifferentiated cell types compared to the MLG group (Table 1) .
Chronologically, the proportion of UTG was 2.6% in 1986 and rapidly increased to 12.5% in 1992. Subsequently, the disease (Fig. 1) . The median age for UTG was in the sixth decade of life from 1986 to 1995. This shifted to the seventh decade of life after 1996, a finding that was also observed in the MLG group. A chronological review of the TNM stage showed that stage I and II cancers were more prevalent in both the UTG and MLG groups than in the past (Fig. 2) . Comparison of the individual stratified TNM stages showed that the 5-year survival rate of the UTG group was significantly poorer than that of the MLG in stage I-III (Fig. 3) .
Tumor size, tumor location, Lauren's classification, cell differentiation, radicality, and TNM stage were identified as prognostic factors in univariate analysis. However, in multivariate analysis, sex, tumor size, tumor location, radicality, and TNM stage were found to be independent prognostic indicators ( Table 2 ).
Discussion
The aim of this study was to evaluate chronological changes in the proportion of UTG during the past 21 years and to determine the prognosis of patients with UTG. In contrast to previous reports of an increasing trend in UTG worldwide, we found that the UTG proportions are nearly not changing these days. Prior to 1992, the prevalence of UTG showed a relatively rapid rise, with rates increasing up to 1.69% annually. However, this rate has decreased to 0.21% per year since 1992 at SNUH (Fig. 1) . Those changes are not likely the result in real incidence but may be attributable to increasing rates of screening for early gastric cancer (EGC); there was a simultaneous increase in the proportion of EGC identified during the same period. The changes may also be due to patient characteristics, with specific types of patients being referred to the (Fig. 2) . Thus, the poor prognosis of UTG may be related to various factors, such as stomach anatomy, very complex lymphatic systems, or technical difficulties during surgery. However, the tumor itself may also be different in UTG compared with MLG. In one analysis, UTG showed a significantly higher incidence of undifferentiated cell types than MLG, a finding consistent with other studies. Maeda et al. (21) reported that UTG had a more aggressive disease course and poorer prognosis due to undifferentiated or poorly differentiated cancer cells leading to advanced gastric cancer. In Lauren's classifications, UTG showed a higher proportion of diffuse type cells, whereas MLG exhibited more intestinal type cells (Table 1) , all of which may be related to the differences in the pathophysiology of UTG and MLG. KcColl et al. (22) In our study, early stage UTG showed nearly a 90% 5-year survival rate, suggesting that more effort should be expended on the early detection and treatment of upper third gastric lesions. As noted previously by Yokoi et al., (26) there are some limitations associated with UTG screening, such as the presence of trivial mucosal lesions, simple color changes, and technical difficulties. To ensure that UTG lesions are not overlooked, the endoscopist should pay special attention when examining lesions in the upper third stomach.
As this was a retrospective analysis and patients who did not undergo surgery because of advanced disease were not included, our study does not represent all the clinical aspects of UTG in Korea. However, from a surgical perspective, it may offer useful information.
In conclusion, the prevalence of UTG showed a temporary increasing trend prior to the 1990s, with an annual rise of 1.69%.
However, since then, the annual rate of increase has been just 0.21% at SNUH. The UTG group showed significantly poorer 5-year survival rates compared with the MLG group in each TNM stage except stage IV. Tumor size, tumor location, radicality, and TNM stage were independent prognostic indicators in both univariate and multivariate analysis.
